Naturally acquired antibody responses to recombinant Pfs230 and Pfs48/45 transmission blocking vaccine candidates.

[1]  T. Bousema,et al.  A multi-stage malaria vaccine candidate targeting both transmission and asexual parasite life-cycle stages. , 2014, Vaccine.

[2]  M. Fay,et al.  Functional Comparison of Plasmodium falciparum Transmission-Blocking Vaccine Candidates by the Standard Membrane-Feeding Assay , 2013, Infection and Immunity.

[3]  J. Cox,et al.  Combined DNA extraction and antibody elution from filter papers for the assessment of malaria transmission intensity in epidemiological studies , 2013, Malaria Journal.

[4]  T. Bousema,et al.  Influence of infection on malaria‐specific antibody dynamics in a cohort exposed to intense malaria transmission in northern Uganda , 2013, Parasite immunology.

[5]  Kwaku Poku Asante,et al.  Trends in multiplicity of Plasmodium falciparum infections among asymptomatic residents in the middle belt of Ghana , 2013, Malaria Journal.

[6]  T. Bousema,et al.  Naturally Acquired Immune Responses to Plasmodium falciparum Sexual Stage Antigens Pfs48/45 and Pfs230 in an Area of Seasonal Transmission , 2011, Infection and Immunity.

[7]  T. Scheike,et al.  Is the current decline in malaria burden in sub-Saharan Africa due to a decrease in vector population? , 2011, Malaria Journal.

[8]  T. Bousema,et al.  Adjusting for heterogeneity of malaria transmission in longitudinal studies. , 2011, The Journal of infectious diseases.

[9]  T. Tsuboi,et al.  A Plant-Produced Pfs230 Vaccine Candidate Blocks Transmission of Plasmodium falciparum , 2011, Clinical and Vaccine Immunology.

[10]  T. Theander,et al.  Accuracy of malaria rapid diagnostic tests in community studies and their impact on treatment of malaria in an area with declining malaria burden in north-eastern Tanzania , 2011, Malaria Journal.

[11]  T. Déirdre Hollingsworth,et al.  The Potential Contribution of Mass Treatment to the Control of Plasmodium falciparum Malaria , 2011, PloS one.

[12]  Teun Bousema,et al.  Epidemiology and Infectivity of Plasmodium falciparum and Plasmodium vivax Gametocytes in Relation to Malaria Control and Elimination , 2011, Clinical Microbiology Reviews.

[13]  T. Bousema,et al.  The Dynamics of Naturally Acquired Immune Responses to Plasmodium falciparum Sexual Stage Antigens Pfs230 & Pfs48/45 in a Low Endemic Area in Tanzania , 2010, PloS one.

[14]  Wes Hinsley,et al.  Reducing Plasmodium falciparum Malaria Transmission in Africa: A Model-Based Evaluation of Intervention Strategies , 2010, PLoS medicine.

[15]  I. Mueller,et al.  Comparison of Plasmodium falciparum allelic frequency distribution in different endemic settings by high-resolution genotyping , 2009, Malaria Journal.

[16]  R. Snow,et al.  The use of schools for malaria surveillance and programme evaluation in Africa , 2009, Malaria Journal.

[17]  Karen I Barnes,et al.  Impact of the large-scale deployment of artemether/lumefantrine on the malaria disease burden in Africa: case studies of South Africa, Zambia and Ethiopia , 2009, Malaria Journal.

[18]  E. Angov,et al.  A Potent Malaria Transmission Blocking Vaccine Based on Codon Harmonized Full Length Pfs48/45 Expressed in Escherichia coli , 2009, PloS one.

[19]  Andreas Mårtensson,et al.  Optimization and validation of multi-coloured capillary electrophoresis for genotyping of Plasmodium falciparum merozoite surface proteins (msp1 and 2) , 2009, Malaria Journal.

[20]  K. Marsh,et al.  Analysis of Immunity to Febrile Malaria in Children That Distinguishes Immunity from Lack of Exposure , 2009, Infection and Immunity.

[21]  B. Greenwood,et al.  Malaria vaccines and their potential role in the elimination of malaria , 2008, Malaria Journal.

[22]  D. Conway,et al.  Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis , 2008, The Lancet.

[23]  Teun Bousema,et al.  Dried blood spots as a source of anti-malarial antibodies for epidemiological studies , 2008, Malaria Journal.

[24]  C. Drakeley,et al.  Plasmodium falciparum Antigens on the Surface of the Gametocyte-Infected Erythrocyte , 2008, PloS one.

[25]  D. Conway,et al.  Evidence of non-neutral polymorphism in Plasmodium falciparum gamete surface protein genes Pfs47 and Pfs48/45. , 2007, Molecular and biochemical parasitology.

[26]  J. Kihonda,et al.  A longitudinal study of immune responses to Plasmodium falciparum sexual stage antigens in Tanzanian adults , 2007, Parasite immunology.

[27]  R. Sauerwein.  Malaria transmission-blocking vaccines: the bonus of effective malaria control. , 2007, Microbes and infection.

[28]  R. Sauerwein,et al.  Glutamate-rich protein (GLURP) induces antibodies that inhibit in vitro growth of Plasmodium falciparum in a phase 1 malaria vaccine trial. , 2007, Vaccine.

[29]  C. Drakeley,et al.  Transmission‐reducing immunity is inversely related to age in Plasmodium falciparum gametocyte carriers , 2006, Parasite immunology.

[30]  J. Baird,et al.  Rapid onset of transmission-reducing antibodies in javanese migrants exposed to malaria in papua, indonesia. , 2006, The American journal of tropical medicine and hygiene.

[31]  C. Drakeley,et al.  Sexual-stage antibody responses to P. falciparum in endemic populations. , 2006, Current molecular medicine.

[32]  J. Cox,et al.  Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[33]  C. Drakeley,et al.  Plasmodium falciparum gametocyte carriage in asymptomatic children in western Kenya , 2004, Malaria Journal.

[34]  C. Drakeley,et al.  Parasite infectivity and immunity to Plasmodium falciparum gametocytes in Gambian children , 2004, Parasite immunology.

[35]  D. Conway,et al.  Extreme geographical fixation of variation in the Plasmodium falciparum gamete surface protein gene Pfs48/45 compared with microsatellite loci. , 2001, Molecular and biochemical parasitology.

[36]  G. Leroux-Roels,et al.  Vaccine- and Hepatitis B Immune Globulin-Induced Escape Mutations of Hepatitis B Virus Surface Antigen , 2001, Journal of Biomedical Science.

[37]  R. Carter,et al.  Transmission-blocking immunity to Plasmodium falciparum in malaria-immune individuals is associated with antibodies to the gamete surface protein Pfs230 , 1999, Parasitology.

[38]  L. Ranford-Cartwright,et al.  Genetic structure and dynamics of Plasmodium falciparum infections in the Kilombero region of Tanzania. , 1999, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[39]  D. Arnot,et al.  Unstable malaria in Sudan: the influence of the dry season. Clone multiplicity of Plasmodium falciparum infections in individuals exposed to variable levels of disease transmission. , 1998, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[40]  D. Kaslow,et al.  Transmission-blocking vaccines: uses and current status of development. , 1997, International journal for parasitology.

[41]  M. Bolmer,et al.  Association between anti‐Pfs48/45 reactivity and P. falciparum transmission‐blocking activity in sera from Cameroon , 1996, Parasite immunology.

[42]  F. Lunel,et al.  Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages , 1995, The Journal of Experimental Medicine.

[43]  J. Meuwissen,et al.  Plasmodium falciparum: a comparison of the activity of Pfs230-specific antibodies in an assay of transmission-blocking immunity and specific competition ELISAs. , 1995, Experimental parasitology.

[44]  D. Kaslow.  Transmission-blocking immunity against malaria and other vector-borne diseases. , 1993, Current opinion in immunology.

[45]  T. Burkot,et al.  Antibodies to Plasmodium falciparum gamete surface antigens in Papua New Guinea sera , 1988, Parasite immunology.

[46]  M. Smits,et al.  Sequential expression of antigens on sexual stages of Plasmodium falciparum accessible to transmission-blocking antibodies in the mosquito , 1985, The Journal of experimental medicine.

[47]  B. Nahlen,et al.  Polymorphism in the gene encoding the Pfs48/45 antigen of Plasmodium falciparum. XI. Asembo Bay Cohort Project. , 2002, Molecular and biochemical parasitology.